NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


ADVERTISMENT

ADVERTISMENT

Resistance and persistence

By Dermot Garland - 26th Feb 2021

Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected, new research shows

Computational research at Chalmers University of Technology, Sweden, has shown that one reason for this rapid development of resistance could be significant genetic transfer between bacteria in our ecosystems and to humans. This work has also led to new tools for resistance researchers.

According to the World Health Organisation, antibiotic resistance is one of the greatest threats to global health, food safety and development. It already causes over 33,000 deaths a year in Europe alone.

Completely different species of bacteria can spread resistance genes to each other through plasmids — small DNA molecules where bacteria store some of their genes outside the chromosome. When two bacterial cells come into contact, they can copy plasmids to each other. This is known as conjugation, and is the most important mechanism for spreading antibiotic resistance.

Pathogens

“In recent years, we’ve seen that resistance genes spread to human pathogens to a much greater degree than anyone expected,” said Dr Jan Zrimec (PhD), researcher in systems and synthetic biology at Chalmers University of Technology. “Many of the genes appear to have originated in a wide array of bacterial species and environments, such as soil, water and plant bacteria.

“This has been difficult to explain, because although conjugation is very common, we’ve thought that there was a distinct limitation for which bacterial species can transfer plasmids to each other. Plasmids belong to different mobility groups, or MOB groups, so they can’t transfer between just any bacterial species.”

Dr Zrimec has developed new methods of data analysis that show that genetic transfer may be much more boundless and widespread than previously expected. Among other things, he has developed an algorithm that can identify specific DNA regions that are necessary for conjugation — called oriT (origin of transfer) DNA regions — in large amounts of data consisting of genetic sequences from the DNA of thousands of plasmids. The algorithm can also sort plasmids into MOB groups based on the identified oriT regions.

In recent years, we’ve seen that resistance genes spread to human pathogens to a much greater degree than anyone expected

In order for conjugation to start, an enzyme is needed — a relaxase — which fits onto a specific location on the plasmid. The relaxase has to recognise and bind to a region where the DNA ring can be ‘nicked’ and a strand can be transferred to the next bacterium.

He used the algorithm to explore known gene sequences from over 4,600 naturally occurring plasmids from different types of bacteria, which had not been possible to do systematically previously. The results show, among other things, that:

  • The number of oriT regions may be almost eight times higher than those found with the standard method used today.
  • The number of mobile plasmids may be twice as high as previously known.
  • The number of bacterial species that have mobile plasmids may be almost twice as high as previously known.
  • Over half of these plasmids have oriT regions that match a conjugation enzyme from another plasmid that has previously been classified in a different MOB group. This means that they could be transferred by one of these plasmids that happens to be in the same bacterial cell.

“The last part means that there may be transfer mechanisms between large numbers of bacterial species and environments where we previously believed there were barriers,” he said.

“These results could imply that there is a robust network for transferring plasmids between bacteria in humans, animals, plants, soil, aquatic environments and industries, to name a few,” Dr Zrimec explained. “Resistance genes occur naturally in many different bacteria in these ecosystems, and the hypothetical network could mean that genes from all of these environments can be transferred to bacteria that cause disease in humans.

“This may be a possible reason for the rapid development of resistance in human pathogens that we have observed in recent years. Our extensive use of antibiotics selects for resistance genes, which could thus flow in from a much larger naturally occurring genetic reservoir than we previously estimated.”

Antibiotic resistance

The results need to be verified experimentally in the future, but the data analysis methods Dr Zrimec developed
can already be employed by many researchers working with antibiotic resistance in various fields. They provide a powerful new tool for systematically mapping-out the potential transferability of different plasmids.

“This has been a major limitation of the research field up to now,” Dr Zrimec said. “I hope that the methods will be able to benefit large parts of the research into antibiotic resistance, which is an extremely interdisciplinary and fragmented area. The methods can be used for studies aiming to develop more effective limitations to antibiotic use, instructions for how antibiotics are to be used, and new types of substances that can prevent the spread of resistance genes at the molecular level.” 

Previously, it was thought that an individual plasmid must contain both the gene for the relaxase and a matching oriT in order to be transferred to other bacteria. But a bacterial cell can contain several plasmids, and in recent years various researchers have shown that a relaxase from one plasmid can fit with an oriT region on another plasmid in the same cell and activate the conjugation of that plasmid.

This means that it may be enough for a plasmid to have only an oriT to be able to conjugate, which in turn means that many plasmids that have previously been classed as non-mobile, because they lack the relaxase gene, can be conjugative. But until now, it has not been known how common the phenomenon is among bacteria. This is one of the knowledge gaps that Dr Zrimec’s results are helping to fill in.

The current standard tools for assessing the transferability of plasmids are based on searching for the DNA sequences for the relaxase enzyme or for oriT regions that the enzyme can bind to. There are several key limitations to this, said Dr Zrimec. For instance, some tools produce incomplete results, while others require extremely time-consuming and resource-demanding laboratory tests.


The new data analysis method is based solely on identifying oriT regions, using special physiochemical properties found specifically in oriT regions of DNA. Through previous research, he has shown that these physiochemical signatures — which determine which relaxase can bind to the oriT region — are more stable and specific than the DNA sequences themselves.

This allows the classification of the plasmids to the right MOB group based on the oriT region, independently of relaxase, which also allows researchers to map out the overall transferability between different bacterial species and environments.

The method can manage large amounts of data and can be used to search effectively for oriT regions on plasmids in their entirety.

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist April 2024

Volume 25 | Issue 4 | April 2024. Read the latest issue of Irish Pharmacist here.

Read

OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT